| pubmed-article:2885320 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2885320 | lifeskim:mentions | umls-concept:C0072108 | lld:lifeskim |
| pubmed-article:2885320 | lifeskim:mentions | umls-concept:C0021764 | lld:lifeskim |
| pubmed-article:2885320 | lifeskim:mentions | umls-concept:C0079183 | lld:lifeskim |
| pubmed-article:2885320 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:2885320 | pubmed:issue | 18 | lld:pubmed |
| pubmed-article:2885320 | pubmed:dateCreated | 1987-7-29 | lld:pubmed |
| pubmed-article:2885320 | pubmed:abstractText | Previously, we have shown that a protein designated p36 is synthesized at a high rate during interleukin 2-driven proliferation of a cloned T lymphocyte, L2. Biosynthesis of p36 increases 1000-fold during the initial mid-G1 phase of the cell cycle and remains high while the cells proliferate. In this report, we show that p36 has the same migration pattern by two-dimensional gel electrophoresis as proliferating cell nuclear antigen (PCNA)/cyclin and that antiserum to PCNA/cyclin selectively immunoprecipitates p36. In addition, by indirect immunofluorescence, PCNA/cyclin accumulates in the nucleus of interleukin 2-stimulated L2 cells during proliferation and is not detectable prior to the initial S phase or after proliferation ceases. These data indicate that PCNA/cyclin expression is induced by interleukin 2 and that PCNA/cyclin accumulation is closely associated with T lymphocyte proliferation. | lld:pubmed |
| pubmed-article:2885320 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2885320 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2885320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2885320 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2885320 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:2885320 | pubmed:issn | 0021-9258 | lld:pubmed |
| pubmed-article:2885320 | pubmed:author | pubmed-author:TanE MEM | lld:pubmed |
| pubmed-article:2885320 | pubmed:author | pubmed-author:PrystowskyM... | lld:pubmed |
| pubmed-article:2885320 | pubmed:author | pubmed-author:SullivanKK | lld:pubmed |
| pubmed-article:2885320 | pubmed:author | pubmed-author:MooreK SKS | lld:pubmed |
| pubmed-article:2885320 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2885320 | pubmed:day | 25 | lld:pubmed |
| pubmed-article:2885320 | pubmed:volume | 262 | lld:pubmed |
| pubmed-article:2885320 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2885320 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2885320 | pubmed:pagination | 8447-50 | lld:pubmed |
| pubmed-article:2885320 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:meshHeading | pubmed-meshheading:2885320-... | lld:pubmed |
| pubmed-article:2885320 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:2885320 | pubmed:articleTitle | Proliferating cell nuclear antigen/cyclin is an interleukin 2-responsive gene. | lld:pubmed |
| pubmed-article:2885320 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2885320 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2885320 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2885320 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2885320 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2885320 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2885320 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2885320 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2885320 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2885320 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2885320 | lld:pubmed |
